VLON Stock News

Popular stocks:

NVIDIA

TOP Stocks:

Shares of other companies:

Chicago Atlantic Real Estate Finance

Ally Financial

Alexandria Real Estate Equities

Pioneer Natural Resources

Vallon Pharmaceuticals (VLON) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 5, 2023 (16:14)

Sector: Healthcare

The share price of Vallon Pharmaceuticals, Inc. (VLON) now

Latest session on the 5th of December for

Vallon Pharmaceuticals, Inc. is negative

Trading Volume: 1613639

Open: 0.635 / High: 0.648 / Low: 0.523

What analysts predict: $

52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Vallon Pharmaceuticals stocks, the 50-day moving average is the support level today.

For Vallon Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in Vallon Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Vallon Pharmaceuticals stock price in 2023, 2024, 2025, 2026, 2027. How much will one Vallon Pharmaceuticals share be worth in 2023 - 2027?

When should I take profit in Vallon Pharmaceuticals stock? When should I record a loss on Vallon Pharmaceuticals stock? What are analysts' forecasts for Vallon Pharmaceuticals stock? What is the future of Vallon Pharmaceuticals stock? We forecast Vallon Pharmaceuticals stock performance using neural networks based on historical data on Vallon Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Vallon Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Vallon Pharmaceuticals shares. This happens once a day.

Historical and forecast chart of Vallon Pharmaceuticals stock

The chart below shows the historical price of Vallon Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Vallon Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Vallon Pharmaceuticals is a clinical stage biopharmaceutical company specializing in the development and commercialization of new drugs to control abuse in CNS disorders.

Vallon Pharmaceuticals daily forecast for a month

Date	Target	Pes.	Opt.	Vol., %
Dec 07	0.71	0.68	0.73	7.36
Dec 08	0.70	0.68	0.73	7.38
Dec 09	0.70	0.69	0.73	5.74
Dec 10	0.71	0.69	0.72	3.97
Dec 11	0.70	0.67	0.73	8.28
Dec 12	0.72	0.71	0.75	5.92
Dec 13	0.70	0.67	0.73	8.56
Dec 14	0.71	0.69	0.74	6.37
Dec 15	0.74	0.73	0.76	4.84
Dec 16	0.76	0.73	0.79	8.68
Dec 17	0.78	0.76	0.79	4.87
Dec 18	0.81	0.79	0.84	6.52
Dec 19	0.81	0.80	0.84	5.74
Dec 20	0.81	0.79	0.83	5.03
Dec 21	0.80	0.77	0.82	5.68
Dec 22	0.81	0.79	0.83	4.39
Dec 23	0.80	0.78	0.82	5.11
Dec 24	0.85	0.82	0.86	4.52
Dec 25	0.84	0.82	0.85	4.04
Dec 26	0.81	0.78	0.82	4.20
Dec 27	0.81	0.80	0.82	2.49
Dec 28	0.79	0.77	0.81	5.62
Dec 29	0.77	0.75	0.80	7.14
Dec 30	0.78	0.74	0.79	5.94
Dec 31	0.80	0.76	0.83	9.74
Jan 01	0.83	0.81	0.85	3.92
Jan 02	0.85	0.83	0.88	6.15
Jan 03	0.81	0.79	0.84	7.02
Jan 04	0.80	0.77	0.83	8.92
Jan 05	0.77	0.76	0.79	3.17

Vallon Pharmaceuticals Daily Price Targets

Vallon Pharmaceuticals Stock Forecast 12-07-2023.

Forecast target price for 12-07-2023: $0.71.
Negative dynamics for Vallon Pharmaceuticals shares will prevail with possible volatility of 6.858%.
Pessimistic target level: 0.68
Optimistic target level: 0.73

Vallon Pharmaceuticals Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $0.70.
Negative dynamics for Vallon Pharmaceuticals shares will prevail with possible volatility of 6.872%.
Pessimistic target level: 0.68
Optimistic target level: 0.73

Vallon Pharmaceuticals Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $0.70.
Negative dynamics for Vallon Pharmaceuticals shares will prevail with possible volatility of 5.425%.
Pessimistic target level: 0.69
Optimistic target level: 0.73

Vallon Pharmaceuticals Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $0.71.
Positive dynamics for Vallon Pharmaceuticals shares will prevail with possible volatility of 3.820%.
Pessimistic target level: 0.69
Optimistic target level: 0.72

Vallon Pharmaceuticals Stock Forecast 12-11-2023.

Forecast target price for 12-11-2023: $0.70.
Negative dynamics for Vallon Pharmaceuticals shares will prevail with possible volatility of 7.645%.
Pessimistic target level: 0.67
Optimistic target level: 0.73

Vallon Pharmaceuticals Stock Forecast 12-12-2023.

Forecast target price for 12-12-2023: $0.72.
Positive dynamics for Vallon Pharmaceuticals shares will prevail with possible volatility of 5.585%.
Pessimistic target level: 0.71
Optimistic target level: 0.75

VLON (VLON) Monthly Stock Prediction for 2023

Month	Target	Pes.	Opt.	Vol., %
Dec.	0.49	0.42	0.55	23.42

Full forecast for 2023

Vallon Pharmaceuticals forecast for this year

Vallon Pharmaceuticals Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $0.490048. Pessimistic: $0.42. Optimistic: $0.55

Vallon Pharmaceuticals (VLON) Monthly Stock Prediction for 2024

Month	Target	Pes.	Opt.	Vol., %
Jan	0.47	0.43	0.49	12.62
Feb	0.47	0.43	0.53	18.18
Mar	0.48	0.45	0.53	13.94
Apr	0.42	0.39	0.47	17.69
May	0.45	0.42	0.50	15.78
Jun	0.53	0.47	0.57	18.03
Jul	0.54	0.49	0.59	16.65
Aug	0.51	0.47	0.53	11.48
Sep	0.52	0.46	0.53	14.77
Oct	0.48	0.45	0.51	11.22
Nov	0.45	0.42	0.52	18.94
Dec	0.52	0.46	0.54	14.40

Full forecast for 2024

Vallon Pharmaceuticals (VLON) Monthly Stock Prediction for 2025

Month	Target	Pes.	Opt.	Vol., %
Jan	0.55	0.48	0.62	21.65
Mar	0.63	0.61	0.72	15.81
Mar	0.67	0.62	0.74	16.13
Apr	0.63	0.54	0.71	23.30
May	0.62	0.55	0.66	15.84
Jun	0.65	0.61	0.72	14.55
Jul	0.58	0.51	0.61	16.34
Aug	0.50	0.44	0.54	19.28
Sep	0.48	0.43	0.52	17.73
Oct	0.52	0.50	0.56	11.30
Nov	0.59	0.50	0.66	23.49
Dec	0.67	0.60	0.74	18.80

Full forecast for 2025

Vallon Pharmaceuticals (VLON) Monthly Stock Prediction for 2026

Month	Target	Pes.	Opt.	Vol., %
Jan	0.67	0.62	0.73	15.24
Mar	0.73	0.65	0.82	20.37
Mar	0.72	0.67	0.77	12.45
Apr	0.71	0.62	0.81	23.55
May	0.72	0.65	0.80	18.98
Jun	0.78	0.73	0.89	18.60
Jul	0.87	0.79	0.98	19.18
Aug	0.84	0.79	0.93	15.41
Sep	0.96	0.91	1.01	9.94
Oct	0.95	0.82	1.07	23.54
Nov	1.05	0.91	1.10	16.68
Dec	0.98	0.85	1.11	23.63

Full forecast for 2026

Vallon Pharmaceuticals (VLON) Monthly Stock Prediction for 2027

Month	Target	Pes.	Opt.	Vol., %
Jan	0.92	0.86	0.99	12.64
Mar	0.86	0.74	0.93	19.88
Mar	0.73	0.69	0.83	16.12
Apr	0.69	0.66	0.72	9.07
May	0.70	0.64	0.77	16.93
Jun	0.66	0.61	0.72	14.70
Jul	0.78	0.67	0.81	16.62
Aug	0.79	0.75	0.88	14.48
Sep	0.76	0.73	0.85	14.32
Oct	0.71	0.65	0.76	14.85
Nov	0.71	0.67	0.77	13.75
Dec	0.74	0.68	0.80	14.34

Full forecast for 2027

Vallon Pharmaceuticals information and performance

Vallon Pharmaceuticals Address

N/A

Market Capitalization: N/A $

Market capitalization of the Vallon Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of VLON shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Vallon Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: N/A

Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Related stocks from Healthcare sector

Roivant Sciences Ltd. (ROIV)

Zynex, Inc. (ZYXI)

Alkermes plc (ALKS)

Medtronic plc. (MDT)

Exelixis, Inc. (EXEL)

SIGA Technologies, Inc. (SIGA)

Clever Leaves Holdings Inc. (CLVR)

Catalent, Inc. (CTLT)

Gilead Sciences, Inc. (GILD)

GlaxoSmithKline plc (GSK)

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.

<img data-src="/images/stock/VLON.svg" class="img_30 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="img_30" src="/images/stock/VLON.svg"> Vallon Pharmaceuticals (VLON) Stock Forecast for 2023 – 2026. Sell or Buy?